Raymond James & Associates’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-29,198
| Closed | -$199K | – | 4075 |
|
|
2021
Q2 | $199K | Buy |
29,198
+4,738
| +19% | +$32.3K | ﹤0.01% | 3658 |
|
|
2021
Q1 | $173K | Sell |
24,460
-101,748
| -81% | -$720K | ﹤0.01% | 3607 |
|
|
2020
Q4 | $790K | Sell |
126,208
-11,554
| -8% | -$72.3K | ﹤0.01% | 2485 |
|
|
2020
Q3 | $745K | Buy |
137,762
+101,864
| +284% | +$551K | ﹤0.01% | 2353 |
|
|
2020
Q2 | $187K | Sell |
35,898
-1,050
| -3% | -$5.47K | ﹤0.01% | 3131 |
|
|
2020
Q1 | $116K | Sell |
36,948
-9,400
| -20% | -$29.5K | ﹤0.01% | 3164 |
|
|
2019
Q4 | $187K | Sell |
46,348
-11,975
| -21% | -$48.3K | ﹤0.01% | 3337 |
|
|
2019
Q3 | $252K | Sell |
58,323
-25,800
| -31% | -$111K | ﹤0.01% | 3091 |
|
|
2019
Q2 | $336K | Sell |
84,123
-5,742
| -6% | -$22.9K | ﹤0.01% | 2919 |
|
|
2019
Q1 | $482K | Sell |
89,865
-8,663
| -9% | -$46.5K | ﹤0.01% | 2660 |
|
|
2018
Q4 | $505K | Sell |
98,528
-147
| -0.1% | -$753 | ﹤0.01% | 2548 |
|
|
2018
Q3 | $957K | Buy |
98,675
+10,102
| +11% | +$98K | ﹤0.01% | 2281 |
|
|
2018
Q2 | $903K | Buy |
88,573
+79
| +0.1% | +$805 | ﹤0.01% | 2284 |
|
|
2018
Q1 | $1.15M | Buy |
88,494
+64,337
| +266% | +$836K | ﹤0.01% | 2032 |
|
|
2017
Q4 | $432K | Buy |
24,157
+12,632
| +110% | +$226K | ﹤0.01% | 2611 |
|
|
2017
Q3 | $289K | Buy |
+11,525
| New | +$289K | ﹤0.01% | 2806 |
|